[1]
|
Collée, J., Mawet, M., Tebache, L., Nisolle, M. and Brichant, G. (2021) Polycystic Ovarian Syndrome and Infertility: Overview and Insights of the Putative Treatments. Gynecological Endocrinology, 37, 869-874.
https://doi.org/10.1080/09513590.2021.1958310
|
[2]
|
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Poly-cystic Ovary Syndrome (PCOS). Human Reproduction, 19, 41-47. https://doi.org/10.1093/humrep/deh098
|
[3]
|
朱念念, 冯小凤, 许舒晴. 不同月经稀发程度多囊卵巢综合征患者AMH、FSH、LH、E2水平观察[J]. 中国现代医学杂志, 2023, 33(17): 62-66.
|
[4]
|
李丽丽. 血清AMH、性激素及维生素D联合检测在多囊卵巢综合征中的应用价值[J]. 检验医学与临床, 2023, 20(11): 1550-1552.
|
[5]
|
胡斌. 抗苗勒管激素和内分泌代谢指标在多囊卵巢综合征诊断中的应用[J]. 当代医学, 2020, 26(26): 153-154.
|
[6]
|
汪宗玉. 不同表型PCOS患者间BMI与性激素及胰岛素抵抗的相关性研究[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2023. https://doi.org/10.27202/d.cnki.gkmyc.2022.000798
|
[7]
|
葛亚杰. 多囊卵巢综合征发病相关因素及内分泌代谢特征的临床研究[D]: [硕士学位论文]. 长春: 吉林大学, 2023. https://doi.org/10.27162/d.cnki.gjlin.2023.006054
|
[8]
|
Al Amer, S. (2009) Polycystic Ovarian Syndrome: Diag-nosis and Management of Related Infertility. Obstetrics, Gynaecology and Reproductive Medicine, 19, 263-270. https://doi.org/10.1016/j.ogrm.2009.06.006
|
[9]
|
李晓敏, 黄文洁, 卢永超. 多囊卵巢综合征排卵障碍的发生机制[J]. 中国医药导刊, 2021, 23(7): 486-490.
|
[10]
|
Catteau-Jonard, S., Brunel, A., Dumont, A., Robin, G., Pigny, P. and Dewailly, D. (2019) Serum FSH Level Is Lower in Dysovulating than in Ovulating Non-PCOS Obese Women, In-dependently of Body Mass Index. Annales d’Endocrinologie (Paris), 80, 225-228. https://doi.org/10.1016/j.ando.2018.11.003
|
[11]
|
Aversa, A., La Vignera, S., Rago, R., Gambineri, A., Nappi, R.E., Calogero, A.E. and Ferlin, A. (2020) Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Frontiers in Endocrinology (Lausanne), 11, Article No. 516. https://doi.org/10.3389/fendo.2020.00516
|
[12]
|
李嘉星, 孙贇. 多囊卵巢综合征患者子宫内膜孕激素抵抗研究进展[J]. 中华生殖与避孕杂志, 2020, 40(10): 823-827. https://doi.org/10.3760/cma.j.cn101441-20191022-00476
|
[13]
|
Qi, J., Li, J., Wang, Y., Wang, W., Zhu, Q., He, Y., et al. (2021) Novel Role of CXCL14 in Modulating STAR Expression in Luteinized Granulosa Cells: Implication for Progesterone Synthesis in PCOS Patients. Translational Research, 230, 55-67. https://doi.org/10.1016/j.trsl.2020.10.009
|
[14]
|
Doi, S.A., Al-Zaid, M., Towers, P.A., Scott, C.J. and Al-Shoumer, K.A. (2005) Irregular Cycles and Steroid Hormones in Polycystic Ovary Syndrome. Human Reproduction, 20, 2402-2408. https://doi.org/10.1093/humrep/dei093
|
[15]
|
陈圆辉, 韩笑, 张瑞晓. 多囊卵巢综合征女性胰岛素抵抗对体外受精-胚胎移植助孕结局的影响[J]. 中华生殖与避孕杂志, 2023, 43(1): 50-56.
|
[16]
|
厉心愉, 孙贇. 多囊卵巢综合征患者卵巢局部胰岛素抵抗研究进展[J]. 中华生殖与避孕杂志, 2020, 40(10): 819-822. https://doi.org/10.3760/cma.j.cn101441-20191009-00443
|
[17]
|
温煦, 刘凌燕. 胰岛素抵抗型多囊卵巢综合征的发病机制及治疗进展[J]. 医学研究杂志, 2018, 47(12): 15-18+21.
|
[18]
|
刘音, 鲁娣, 宋殿荣. 胰岛素抵抗对多囊卵巢综合征生殖内分泌及代谢的影响[J]. 国际妇产科学杂志, 2023, 50(2): 190-195.
|
[19]
|
黄晓燕. PCOS患者的BMI和脂代谢对GnRH拮抗剂方案结局的影响[D]: [硕士学位论文]. 南京: 南京医科大学, 2018.
|
[20]
|
Homburg, R. (2004) Management of Infertility and Prevention of Ovarian Hyperstimulation in Women with Polycystic Ovary Syn-drome. Best Practice & Research Clinical Obstetrics & Gynaecology, 18, 773-788.
https://doi.org/10.1016/j.bpobgyn.2004.05.006
|
[21]
|
李尚为, 汪燕, 李蕾. 多囊卵巢综合征高流产率的原因及预防[J]. 中国实用妇科与产科杂志, 2007, 23(9): 682-684. https://doi.org/10.3969/j.issn.1005-2216.2007.09.010
|
[22]
|
袁瑞. 多囊卵巢综合征患者体重指数与胰岛素抵抗及糖脂代谢的相关性分析[D]: [硕士学位论文]. 西安: 西安医学院, 2021.
|
[23]
|
孙聪聪, 蒋鹏. 多囊卵巢综合征患者发生妊娠期糖尿病危险因素分析[J]. 中国现代医生, 2020, 58(4): 57-59.
|
[24]
|
田正平, 姚军. 多囊卵巢综合征患者体外受精-胚胎移植术后妊娠期合并症的研究进展[J]. 华夏医学, 2017, 30(5): 141-145. https://doi.org/10.19296/j.cnki.1008-2409.2017-05-045
|
[25]
|
石文昕, 郭敏, 孔敏, 等. 妊娠期糖尿病一日门诊对孕妇血糖控制和妊娠结局影响的Meta分析[J]. 护士进修杂志, 2023, 38(9): 804-810. https://doi.org/10.16821/j.cnki.hsjx.2023.09.007
|
[26]
|
(2021) Queensland Clinical Guidelines. Gestational Diabetes Mellitus (GDM). http://health.qld.gov.au/qcg
|
[27]
|
Wang, Y., Zhao, X., Zhao, H., Ding, H., Tan, J., Chen, J., et al. (2013) Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome. BioMed Research International, 2013, Article ID: 182582. https://doi.org/10.1155/2013/182582
|
[28]
|
施培花, 潘莉, 费辉辉. 不同孕期多囊卵巢综合征患者发生妊娠期高血压疾病风险预测模型构建与验证[J]. 中国妇幼保健, 2022, 37(14): 2605-2609. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2022.14.023
|
[29]
|
唐晓慧, 李海艳. 妊娠晚期多囊卵巢综合征患者发生妊娠期高血压的危险因素探讨及风险模型建立[J]. 中国性科学, 2020, 29(5): 56-60.
|
[30]
|
赵文华. 多囊卵巢综合征病人妊娠并发症的临床观察[J]. 内蒙古医科大学学报, 2019, 41(2): 121-125.
https://doi.org/10.16343/j.cnki.issn.2095-512x.2019.02.003
|
[31]
|
韦冰. 妊娠期高血压高危因素分析及护理干预对母婴结局的影响[J]. 中国乡村医药, 2019, 26(2): 60-61.
https://doi.org/10.19542/j.cnki.1006-5180.002532
|
[32]
|
潘峥嵘, 姚军. AMH在多囊卵巢综合征患者IVF-ET中的应用进展[J]. 华夏医学, 2017, 30(2): 145-148.
https://doi.org/10.19296/j.cnki.1008-2409.2017-02-046
|
[33]
|
Sun, B., Ma, Y., Li, L., Hu, L., Wang, F., Zhang, Y., Dai, S. and Sun, Y. (2021) Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women with Polycystic Ovary Syndrome Undergoing IVF/ICSI. Frontiers in Endocrinology (Lausanne), 11, Article ID: 615957. https://doi.org/10.3389/fendo.2020.615957
|
[34]
|
周灿权, 乔杰. 辅助生殖临床技术[M]. 北京: 人民卫生出版社, 2021.
|
[35]
|
任艳萍, 许世博, 张嘉乐, 等. 褪黑素对卵巢过度刺激综合征小鼠的影响[J]. 中华生殖与避孕杂志, 2019, 39(1): 30-35. https://doi.org/10.3760/cma.j.issn.2096-2916.2019.01.007
|